VistaGen Therapeutics (VTGN)
(Delayed Data from NSDQ)
$3.41 USD
0.00 (0.00%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $3.39 -0.02 (-0.59%) 7:58 PM ET
5-Strong Sell of 5 5
F Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: AMC |
6/2024 | $-0.41 | 0.00% |
Earnings Summary
For their last quarter, VistaGen Therapeutics (VTGN) reported earnings of -$0.25 per share, beating the Zacks Consensus Estimate of $-0.34 per share. This reflects a positive earnings surprise of 26.47%. Look out for VTGN's next earnings release on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.41 per share, reflecting a year-over-year increase of 56.38%.
Earnings History
Price & Consensus
Zacks News for VTGN
ADC Therapeutics SA (ADCT) Reports Q2 Loss, Lags Revenue Estimates
VTGN: What are Zacks experts saying now?
Zacks Private Portfolio Services